Clinical Trial Update: Ivabradine and Post-revascularisation Microcirculatory Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial of ivabradine for post-revascularisation microcirculatory dysfunction was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Coronary Artery Disease

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust | Conditions: Coronary Artery Disease, Angina | Phase 4 | Status: WITHDRAWN